katie thomasmarch first glance bill passed house representatives week seems like kind thing anyone could get behind known right try legislation would allow terminally ill patients access experimental drugs without approval food drug administration bill similar one passed last summer senate little address main barrier patients face getting unapproved treatments permission drug companies recent years arrival breakthrough drugs everything cancer rare diseases led surge number patients wanting early access treatments pleas sometimes driven viral social media campaigns proved vexing companies invested millions get drug market wary anything jeopardize chances today companies policies granting early access drugs confusing patchwork tends favor affluent well connected patients leading medical centers resources know navigate system pretty sophisticated said dr arthur l caplan bioethicist new york university working companies including johnson johnson develop better early access programs bill passed week said somewhere nothing absolutely nothing help bill passage represented victory proponents right try campaign championed vice president mike pence initiated goldwater institute libertarian think tank favors limiting scope f least states passed local versions right try laws allow patients sidestep f approval received permission company right try measures opposed broad coalition groups contend bill help patients undermine authority primary regulatory agency f four former f commissioners including two democratic republican administrations oppose bills dozens patient groups including american cancer society cancer action network american lung association pharmaceutical industry taking position issue circumspect spokesman main lobbying group pharmaceutical research manufacturers america said friday believe legislation must truly benefit protect patients disrupt future clinical trials u food drug administration oversight research approval new medicines bill future unclear thursday senator ron johnson republican wisconsin failed secure unanimous consent senate pass house version bill blocked senator chuck schumer democratic leader new york mr schumer said senate already passed version wanted work compromise bill statement senator johnson said next step would persuade house pass version patients families running time mr johnson said statement promise continue work tirelessly behalf desperate patients right try right hope supporters say right try measures eliminate unnecessary layer bureaucracy obtaining approval f legislation includes incentives say could encourage companies participate shielding lawsuits preventing f considering experiences patients drugs eventual decisions whether approve trying right try open another avenue patients need served existing programs said starlee coleman senior policy adviser goldwater institute f already approves percent applications agency streamlined approval process drug companies also many reasons bar access often companies enough extra product give patients worry logistical work granting access could slow efforts get drug approved would become available patient needed also possibility drug work many experimental products fail late stage trials please verify youre robot clicking box invalid email address please enter must select newsletter subscribe view new york times newsletters going fix problem still lot reasons companies choose share drugs said nancy goodman founder executive director kids v cancer advocacy group helps connect patients companies offering early access treatment ms goodman son jacob died age cancer said asked eight companies access experimental therapies turned every time ms goodman said dying patients need better access drugs described uncomfortable period consensus drug works reaches market still said companies understand say even though heart broken many times companies said would continue seek f permission even right try bill becomes law view f plays really important role dr joanne waldstreicher chief medical officer johnson johnson said interview thursday johnson johnson initiated program delegates decisions early access program set dr caplan f dr waldstreicher said information necessarily see safety efficacy information products may similar always clear patients would benefit law including whose names included bills title house senate versions carry name jordan mclinn indiana boy duchenne muscular dystrophy degenerative ultimately fatal disease cure jordan mother laura mclinn campaigned mr pence favor law video featured goldwater institute website video ms mclinn discusses unnamed medicine said believed would allow son live long productive life separate remarks public event february ms mclinn said son clinical trial experimental drug email message thursday said journey evolved time right try adding drug presently trying access said still supported measure option pathway makes sense works treatment may want access future ms coleman goldwater institute said video mclinns three years old laura statements accurate time still reflective situation many patients experience recent years companies developed formal policies often called compassionate use wake high profile campaigns dying patients families executives biotechnology company chimerix received death threats refusing give experimental drug year old boy josh hardy virginia dying viral infection company ultimately provided drug boy episode led departure chief executive kenneth moch since become proponent granting fairer access experimental drugs josh died age complications rare cancer hardy family made request mr moch said company flooded pleas ranging longtime friends billionaire seeking access drug brincidofovir still approved f get requests make judgment said since episode said dozens companies contacted advice addition ms goodman group another organization reagan udall foundation also provides information company programs mr moch others oppose legislation acknowledged served positive purpose good thing see coming right try legislation increased awareness within medical community expanded access said version article appears print march page new york edition headline terminally ill people convoluted procedure give drugs try order reprints todays paper subscribe interested feedback page tell us think go home page